IGSF6 and neoplasm: Moreover, expression of IGSF6 correlated with tumor-infiltrating lymphocytes were confirmed in GSE39582 dataset (Supplementary Fig. 1), which supported that IGSF6 could be a potential biomarker to improve clinical applications of current immunotherapies.